Non-stroke neurological syndromes associated with antiphospholipid antibodies: Evaluation of clinical and experimental studies Article Conference Paper uri icon

Overview

MeSH Major

  • Blood Platelets
  • Cycloheptanes
  • Hydroxyquinolines
  • Indium
  • Organometallic Compounds
  • Oxyquinoline
  • Radioisotopes
  • Tropolone

abstract

  • Although many types of neurological disorders and events have been described in association with antiphospholipid antibodies (aPL) and the antiphospholipid syndrome (APS), only ischaemic stroke is reasonably well established and accepted as a diagnostic criterion for the syndrome. We propose to evaluate, classify and rank the association of other neurological manifestations as possible, probable, or definite according to the data available from clinical studies and animal models. By these criteria, none of the neurological disorders or events such as epilepsy, psychiatric disease, dementia, transverse myelitis, multiple sclerosis-like disease, chorea, migraine, Guillian-Barrè syndrome, and sensory-neural hearing loss, can be definitely associated with aPL or APS.

publication date

  • August 2003

Research

keywords

  • Conference Paper

Identity

Digital Object Identifier (DOI)

  • 10.1191/0961203303lu392oa

PubMed ID

  • 12892390

Additional Document Info

start page

  • 514

end page

  • 517

volume

  • 12

number

  • 7